Page last updated: 2024-09-03

imatinib mesylate and Benign Mastocytoma

imatinib mesylate has been researched along with Benign Mastocytoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amagai, Y; Ishizaka, S; Jang, H; Jung, K; Matsuda, A; Matsuda, H; Nishikawa, S; Oida, K; Tanaka, A1
Kawarai, S; Masuda, K; Matsuda, H; Nishimura, R; Ohmori, K; Sasaki, N; Tanaka, A; Tsujimoto, H; Yasuda, N1
Al-Sarraf, R; Johnson, CS; Malone, EK; Rassnick, KM; Ruslander, DM; Russell, DS; Trump, DL; Wakshlag, JJ1
Breyer, B; Dittrich-Breiholz, O; Dutta, P; Koch, A; Kracht, M; Schneider, H; Tamura, T1

Trials

1 trial(s) available for imatinib mesylate and Benign Mastocytoma

ArticleYear
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
    Veterinary and comparative oncology, 2010, Volume: 8, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Calcitriol; Calcium Channel Agonists; Cell Line, Tumor; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Imatinib Mesylate; Indoles; Lomustine; Male; Mastocytoma; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptors, Calcitriol; Skin Neoplasms; Treatment Outcome; Vinblastine

2010

Other Studies

3 other study(ies) available for imatinib mesylate and Benign Mastocytoma

ArticleYear
Increased expression of the antiapoptotic protein MCL1 in canine mast cell tumors.
    The Journal of veterinary medical science, 2013, Jul-31, Volume: 75, Issue:7

    Topics: Animals; Benzamides; Chromones; Dog Diseases; Dogs; Electrophoresis, Polyacrylamide Gel; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation; Imatinib Mesylate; Janus Kinases; Mastocytoma; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Piperazines; Pyrimidines; Sirolimus; Tyrphostins

2013
Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
    Veterinary immunology and immunopathology, 2008, Nov-15, Volume: 126, Issue:1-2

    Topics: Animals; Base Sequence; Benzamides; Cell Line; Cell Proliferation; Dog Diseases; Dogs; Gene Expression Regulation, Neoplastic; Imatinib Mesylate; Male; Mast Cells; Mastocytoma; Molecular Sequence Data; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines

2008
Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis.
    BMC genomics, 2011, Apr-18, Volume: 12

    Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Profiling; Humans; Imatinib Mesylate; Kruppel-Like Transcription Factors; Mastocytoma; Nerve Growth Factor; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Nerve Growth Factor; Receptor, trkA; RNA Interference; RNA, Small Interfering; Signal Transduction; Smad7 Protein

2011